Williams, Christina

No ORCID on file · 12 papers in corpus
2024
·doi:10.14288/1.0433736
2023
·doi:10.14288/1.0431424

A key clinical problem is identifying the endometriosis patient whose pain is complicated by central nervous system sensitization, where conventional gynecologic treatment (e.g. hormonal therapy or surgery) may not completely alleviate the …

observational 2022
·doi:10.14288/1.0421291

Background: Endometriosis is a complex condition that can negatively affect a woman’s quality of life, including her sleep. This study aims to assess the multifactorial variables associated with poorer quality of sleep in women with endomet…

2022
·doi:10.14288/1.0421289
2022
·doi:10.14288/1.0421294
2022
·doi:10.14288/1.0421293
observational 2022
·doi:10.14288/1.0421292

OBJECTIVES: To determine if pain catastrophizing is independently associated with pain health-related quality-of-life in women with endometriosis, independent of potential confounders. METHODS: Analysis of cross-sectional baseline data from…

2022
·doi:10.14288/1.0421295
2021
·doi:10.14288/1.0392005
observational 2021
·doi:10.14288/1.0392159

Background. Deep dyspareunia, a common symptom in endometriosis, has previously been associated with bladder or pelvic floor tenderness (BPFT), which suggests a role for central nervous system sensitization. The Central Sensitization Invent…

observational 2019
·doi:10.14288/1.0380045

Background. The etiology of endometriosis-associated deep dyspareunia may include direct endometriosis-specific factors (e.g., Stage or invasiveness of disease) and/or indirect contributors such as bladder/pelvic floor dysfunction (e.g., re…

observational 2017
·doi:10.14288/1.0303148

The etiology of deep dyspareunia in endometriosis is unclear. Our objective was to determine whether nerve bundle density in the cul-de-sac/uterosacrals (Zone II) is associated with deep dyspareunia in women with endometriosis. We conducted…